Positive expression of E-cadherin retards more human breast carcinoma cells in G0/G1 phase and its molecular mechanism

Progress in Biochemistry and Biophysics

Volumn 30, Issue 3, 2003, Pages 435-441

  Wu, Heng ^a   Shen, Min Xiong ^a,b   Liang, Yu Long ^a   Duan, Ling Ling ^a   Wang, Li Ying ^a   Xu, Zhen ^a   Zha, Xi Liang ^a  

^a FUDAN UNIVERSITY   (China)

^b HUZHOU UNIVERSITY   (China)

Author keywords

Breast carcinoma cell lines; Cyclin D1; E cadherin; Focal adhesion kinase (FAK); Integrin linked kinase (ILK); Protein kinase B; PTEN

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; CYCLIN D1; FOCAL ADHESION KINASE; INTEGRIN; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PTEN PROTEIN; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOLECULAR MECHANICS; PROTEIN CONTENT; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

EID: 0041328192     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chothia C, Jones E Y. The molecular structure of cell adhesion molecules. Annu Rev Biochem, 1997, 66 (1): 823-862
2. Wijnhoven B P, Dinjens W N, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg, 2000, 87 (8): 992-1005
3. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398 (6726): 422-426
4. Giancotti F G, Ruoslahti E. Integrin signaling. Science, 1999, 285 (5430): 1028-1032
5. Hannigan G E, Leung-Hagesteijn C, Fitz-Gibbon L, et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature, 1996, 379 (6560): 91-96
6. Wu C. ILK interactions. J Cell Sci, 2001, 114 (14): 2549-2550
7. Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 1998, 280 (5369): 1614-1617
8. Shapirol G I, Harper J W. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest, 1999, 104 (12): 1645-1653
9. Nicholson K M, Anderson N G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal, 2002, 14 (5): 381-395
10. Cheng J Q, Godwin A K, Bellacosa A, et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA, 1992, 89 (19): 9267-9271
11. Harbour J W, Luo R X, DeiSanti A, et al. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell, 1999, 98 (8): 859-869
12. Sherr C J, Roberts J M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 1999, 13 (12): 1501-1512
13. Abu-Ghazaleh R, Kabir J, Jia H, et al. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J, 2001, 360 (1): 255-264
14. Persad S, Attwell S, Gray V, et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA, 2000, 97 (7): 3207-3212
15. Yu Z, Fotouhi-Ardakani N, Wu L, et al. PTEN associates with the vault particles in HeLa cells. J Biol Chem, 2002, 277 (43): 40247-40252
16. Dupont J, Renou J P, Shani M, et al. PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J Clin Invest, 2002, 110 (6): 815-825
17. Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J, 1999, 13 (8): 773-780